Mini review · 13 Feb 2026
Conference abstractPublished 17 Oct 2016
Checkpoint blockade in hematology and stem cell transplantation
Mayo Clinic, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Blockade of the immune checkpoints has recently emerged as a paradigm shift in the treatment of solid tumors. Several programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA-4) inhibitors are now approved and are moving to first line therapy in several solid tumors. Other checkpoint blocking agents are in earlier phases of development. These inhibitors have also been investigated in the treatment of hematological malignancies, with significant and durable response rates in Hodgkin Lymphoma. PD-1 inhibitors are also active in non-Hodgkin lymphoma but responses are lower than what is observed in Hodgkin lymphoma. Therefore, several strategies are being employed to enhance the activity of checkpoint blocking agents, such as combination with monoclonal antibodies, other immune modulatory agents or stem cell transplantation. Here, we will review the activity and safety of checkpoint blockade in lymphoma and leukemia and strategies used to enhance their activity. Then, we’ll discuss how we see these therapies being applied in the context of bone marrow transplantation and adoptive T cell therapy.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Hematology & Thromboembolic Diseases.
Opinion · 25 Dec 2025
Clinical Patterns and Systemic Implications of Thromboembolism
Opinion · 25 Dec 2025
Integrating Clinical Risk and Preventive Care in Thromboembolism Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Hematology & Thromboembolic Diseases
- SubjectHaematology
- BylineArticles whose byline prints “Saad Kenderian”

